Journal
STROKE
Volume 45, Issue 6, Pages 1830-1832Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.114.005447
Keywords
biological markers; cerebral infarction; epidemiology; ethnic groups; leukoaraiosis; migraine disorders; risk factors
Categories
Funding
- National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)
- NIH/NINDS [R37 NS 29993]
- American Heart Association SDG [0735387 N]
- NINDS [K24 NS 062737]
- [K02 NS 059729]
- [R01 HL 108623]
Ask authors/readers for more resources
Background and Purpose-Migraine with aura is a risk factor for ischemic stroke. The goals of this study are to examine the association between migraine and subclinical cerebrovascular damage in a race/ethnically diverse older population-based cohort study. Methods-In the Northern Manhattan Study (NOMAS), we quantified subclinical brain infarctions and white matter hyperintensity volumes among participants with self-reported migraine, confirmed by the International Classification of Headache Disorders-2 criteria. Results-Of 546 study participants with imaging and migraine data (41% men; mean age at MRI, 71 +/- 8 years; mostly Hispanic [65%]), those reporting migraine overall had double the odds of subclinical brain infarction (adjusted odds ratio, 2.1; 95% confidence interval, 1.0-4.2) when compared with those reporting no migraine, after adjusting for sociodemographics and vascular risk factors. No association was observed between migraine with or without aura and white matter hyperintensity volume. Conclusions-Migraine may be a risk factor for subclinical brain infarction. Prospective studies are needed in race/ethnically diverse populations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available